HYPE: A bedside tracker can diagnose sleep apnoea without any sensors on your body.
But what does the evidence actually show?
Some contactless devices have encouraging validation against clinical sleep tests, especially for identifying moderate or severe obstructive sleep apnoea. Results are device-specific; an ordinary consumer sleep score cannot rule out the condition or replace an appropriate diagnostic pathway.
What is the hype?
Radar, sound or movement sensors can monitor breathing without worn equipment, potentially making testing easier. The strongest reasonable claim concerns detection by a validated device. The broader promise is that any bedside tracker supplies a reliable diagnosis and severity grade.
The pooled evidence is more substantial than many gadget claims
A systematic review of 28 studies involving 2,653 participants reported good pooled detection of moderate-to-severe obstructive sleep apnoea. Most participants had been referred to a sleep clinic, and prevalence was high. Performance in that setting cannot be assumed for a low-risk general population or a different device. [1]
A specific radar system has been tested
A study of 141 adults compared Sleepiz One+ with polysomnography. Results were encouraging, and adding oxygen measurements improved selected diagnostic measures. That distinction matters: a system supplemented by a worn oximeter is not a completely contactless configuration. The trial validates its tested setup rather than all radar products. [2]
Detecting a case and grading severity differ
A further study in 102 higher-risk patients found useful detection with a contactless radar device, but agreement on mild, moderate and severe categories was considerably poorer. A test may therefore flag a likely problem without measuring its severity accurately enough for every treatment decision. [3]
The UK diagnostic pathway still matters
NICE recommends home respiratory polygraphy for suspected obstructive sleep apnoea/hypopnoea syndrome, with alternatives and further testing in appropriate circumstances. Ongoing symptoms after negative testing can require more investigation. A retail device's reassuring score should not be treated as overriding that clinical assessment. [4]
The catch: limitations and uncertainty
Study participants, diagnostic thresholds, algorithms and reference scoring vary. Sensitivity and specificity do not directly tell an individual their chance of disease; the starting likelihood also matters. Some studies combine extra sensors with the contactless unit, and accuracy for identifying disease can exceed accuracy for grading it.
What this means for you
If you have witnessed breathing pauses, persistent excessive sleepiness or other symptoms, seek an assessment even if a tracker looks reassuring. Ask whether the exact device has been compared with clinical testing and whether its intended role is screening or diagnosis. Clinical home testing may be simpler than you expect and can guide appropriate treatment.
Validated contactless technology can help detection; the generic bedside gadget claim is too broad.
Research & Sources
1. Validity of non-contact methods for diagnosis of Obstructive Sleep Apnea: a systematic review and meta-analysis (2023).
Published abstract; largely sleep-clinic populations.
Read the original source ↗2. Validation of the Sleepiz One+ as a radar-based sensor for contactless diagnosis of sleep apnea (2024).
Published abstract; 141 adults and configuration-specific results.
Read the original source ↗3. Diagnostic performance of a doppler radar-based sleep apnoea testing device (2025).
Published abstract; detection versus severity classification.
Read the original source ↗4. NICE NG202. Obstructive sleep apnoea/hypopnoea syndrome: recommendations.
UK diagnostic guidance checked October 2026.
Read the original source ↗Evidence reviewed: October 2026
This targeted editorial review considered sources available in October 2026. It is not an exhaustive systematic review. Source access and indirect evidence are identified above. Evidence vs Hype provides education, not individual diagnosis or treatment. Original AI-generated featured artwork is conceptual and does not demonstrate a study result. No commercial product was selected or endorsed.